Allergic rhinitis or, as it is commonly known, hay fever, is a reaction to allergens in the air. Most commonly this is a reaction to the pollen count, but can also be to dust, mould or pet hair. This means that hay fever can strike at any time and can be fairly debilitating for the sufferer. It affects around one in five people in the UK.
Symptoms include a runny or blocked nose (fluid is usually clear), sneezing, red and itchy eyes which are often swollen or watering, loss of smell and a headache or an earache. It can affect the sufferer’s ability to think clearly and causes many to be forced to retreat indoors to avoid increased misery.
Unfortunately, there are currently no permanent treatments for hay fever, but there are ways to manage it.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).
